Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.

Authors

Institutions

Publication Details

Journal
Strahlentherapie und Onkologie
Published
2025-09-09
DOI
https://doi.org/10.1007/s00066-025-02453-5
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

Ulrike Schötz, Stefanie Corradini, Daniel Habermehl, Kathrin Hering et al.
Strahlentherapie und Onkologie
Cutaneous lymphoproliferative disorders research
article

Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

Ulrike Schötz, Stefanie Corradini, Daniel Habermehl, Kathrin Hering, Laila König, Cora Waldstein, Andrea Baehr, Khaled Elsayad, Dora Correia, Sebastian Adeberg, Burkhard Greve, Angela Besserer, Oliver Micke, Hans Theodor Eich
article en

Abstract

The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.

Strahlentherapie und OnkologieVol. 201(12)
Goethe University Frankfurt (DE), University of Bern (CH), Universität Hamburg (DE), Philipps University of Marburg (DE), Justus-Liebig-Universität Gießen (DE), Heidelberg University (DE), University Hospital of Bern (CH), University Hospital Heidelberg (DE), LMU Klinikum (DE), Comprehensive Cancer Center Vienna (AT), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Frankfurt (DE), Francis Hospital (DE), Klinikum Ernst von Bergmann (DE), Kantonsspital Aarau (CH), Frankfurt Cancer Institute (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Leipzig University (DE)
Openalex Percentile: Top 57%
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.